Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · IEX Real-Time Price · USD
39.90
+0.17 (0.43%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Astrana Health stock have an average target of 47.75, with a low estimate of 44 and a high estimate of 54. The average target predicts an increase of 19.67% from the current stock price of 39.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 2 |
| Buy | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $45 → $48 | Strong Buy | Maintains | $45 → $48 | +20.30% | Jun 27, 2024 |
| Baird | Baird | Buy Initiates $54 | Buy | Initiates | $54 | +35.34% | May 30, 2024 |
| Stifel | Stifel | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +12.78% | May 8, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $41 → $44 | Hold | Maintains | $41 → $44 | +10.28% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
1.78B
from 1.39B
Increased by 28.58%
Revenue Next Year
2.17B
from 1.78B
Increased by 21.70%
EPS This Year
1.45
from 1.29
Increased by 12.67%
EPS Next Year
1.78
from 1.45
Increased by 22.31%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.0B | 2.6B | 2.8B | 2.4B | 2.6B |
| Avg | 1.8B | 2.2B | 2.5B | 2.4B | 2.6B |
| Low | 1.6B | 1.9B | 2.1B | 2.3B | 2.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 45.2% | 47.6% | 31.0% | -1.4% | 12.0% |
| Avg | 28.6% | 21.7% | 13.5% | -4.3% | 8.8% |
| Low | 18.6% | 5.7% | -4.1% | -8.0% | 4.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.61 | 2.36 | 2.82 |
| Avg | 1.45 | 1.78 | 2.34 |
| Low | 1.23 | 1.45 | 1.85 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 24.5% | 62.5% | 58.9% |
| Avg | 12.7% | 22.3% | 31.4% |
| Low | -5.0% | -0.2% | 4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.